Schedule 13D ownership disclosure
LYRA THERAPEUTICS INC
Security class unavailable · CUSIP: 55234L105
Event date: 2020-05-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-144122
- Form type
- SC 13D
- Filer
- Lyra Therapeutics, Inc.
- CIK
- CIK 1327273
- Filed
- May 15, 2020
- Reporting period
- May 05, 2020
- Description
- Schedule 13D beneficial ownership